WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES
Week 43: 23 October - 29 October 2023
Data as reported by: 17:00; 29 October 2023
...
Democratic Republic of
the Congo
Polio (cVDPV1 and cVDPV2)
186 Cases
0 Deaths
0.0% CFR
EVENT DESCRIPTION
The Democratic Republic of the Congo (DRC) was
certified “wild Polio-free country” by WHO since
November 2015 following zero case of wild Polio
reported in the country since December 2011. However,
regarding vaccine derived polio outbreak, the country
is the most affected in the WHO AFRO region reporting
both circulating vaccine-derived polioviruses (cVDPV1
and cVDPV2 cases).
Since 2017, the country has experienced 23 outbreaks
of vaccine derived Polio, reported in 181 health zones
across 24 provinces. Of the 23 reported outbreaks, 14
(61.0%) ended and nine (39.0%) are still ongoing, with
most cases reported in the southeastern part of the
country, over the last two years (2022 and 2023).
During epidemiological week 41 (ending 15 October
2023), two new cases of cVDPV1 were reported from
two newly affected health zones: Kiambi in Tanganyika
province and Mufunga-Sampwe in Haut Katanga
province. Furthermore, 33 environmental samples
collected in the provincial sites of Kinshasa, Equateur,
Haut Katanga, and Lualaba tested positive for cVDPV2,
of which 85.0% (n=25) were from Kinshasa province.
From epidemiological week 1 to week 41, a total of
186 confirmed circulating vaccine-derived poliovirus
(cVDPV) including 79 (42.5 %) cVDPV1 and 107
(57.5%) cVDPV2 have been reported. Haut Katanga and
Tanganyika provinces were the most affected, with 44
cases (33 cVDPV1 and 11 cVDPV2) and 41 cases (36
cVDPV1 and 5 cVDPV2) respectively.
From 1 January to 19 October 2023, a cumulative total of
3 630 AFP cases have been reported in 98.0% (n=509)
of the 519 health districts, with an estimated no polio AFP
rate of 7.2 per 100 000 population of less than 15 years
old (country target: ≥ 3/100 000). Nearly 60.0% (n=2 083)
of the AFP cases were notified by healthcare providers
(n= 2 083), followed by community health workers
(36.0%, n=1 310), relatives (3.1%, n=113), traditional
healers (0.5%, n=21) and non-government organizations
(0.4%, n=16).
The percentage of AFP cases notified within 7 days of
the onset of paralysis was 67.1% (target: ≥ 80 %), and
only 9.1% (target: ≥ 80%) of the collected samples
reached the laboratory for investigation within 3 days
or less; the remaining samples arrived late.
Since 2017 and as of 20 October 2023, there have
been a cumulative total of 23 648 AFP cases, with 938
(4.0%) confirmed polio cases including 722 (77.0%)
cVDPV2 and 216 (23.0%) cVDPV1. The highest
number of cases was reported in 2022 with a total
of 520 (55.4%) confirmed cVDPV cases, including
377 cVDPV2 and 143 cVDPV1. Haut Lomami and
Tanganyika provinces reported most cases with 185
cases (103 cVDPV1 and 82 cVDPV2) and 163 cases
(103 cVDPV1 and 82 cVDPV2) respectively.
From 20 October 2022 to 19 October 2023, of the
3 644 reported AFP cases, 46% (n=1 676) of those
aged between 6- 59 months, received more than four
Polio vaccine doses, while 16.0% (n=583) had an
unknown vaccination status, and 10.0% (n=365) had
zero Polio vaccine dose.
PUBLIC HEALTH ACTIONS
The Ministry of health is coordinating the
preparation and implementation of polio
vaccination campaigns in the affected provinces
and health zones with support from WHO and
other implementing partners.
WHO continues to support the training of national,
provincial and health zones surveillance officers
on electronic surveillance
Active Polio case search, case investigation and
supportive integrated supervisions in the affected
health zones are ongoing.
Annual review of environmental surveillance sites
is ongoing, and investigations of polioviruses
isolated from environmental samples are
underway.
SITUATION INTERPRETATION
Vaccine derived Polio disease remains a public health
concern in DRC. While efforts have been made to fulfill
two key indicators, namely AFP case investigation
within 48 hours, and stool sample collection adequacy,
there still a need to strengthen cases notification within
7 days of the onset of paralysis and ensure that samples are
shipped to the laboratory within 3 days or less. It’s worth noting
a significant community involvement in reporting AFP
cases, with nearly 36% of AFP cases reported.
The Government along with its partners should
enhance and maintain quality routine polio vaccination
activities, as well as targeted response
efforts in hard-to-reach areas to achieve the
national and global polio eradication objectives.
https://www.afro.who.int/countries/m...-october-2023\[]
AND OTHER EMERGENCIES
Week 43: 23 October - 29 October 2023
Data as reported by: 17:00; 29 October 2023
...
Democratic Republic of
the Congo
Polio (cVDPV1 and cVDPV2)
186 Cases
0 Deaths
0.0% CFR
EVENT DESCRIPTION
The Democratic Republic of the Congo (DRC) was
certified “wild Polio-free country” by WHO since
November 2015 following zero case of wild Polio
reported in the country since December 2011. However,
regarding vaccine derived polio outbreak, the country
is the most affected in the WHO AFRO region reporting
both circulating vaccine-derived polioviruses (cVDPV1
and cVDPV2 cases).
Since 2017, the country has experienced 23 outbreaks
of vaccine derived Polio, reported in 181 health zones
across 24 provinces. Of the 23 reported outbreaks, 14
(61.0%) ended and nine (39.0%) are still ongoing, with
most cases reported in the southeastern part of the
country, over the last two years (2022 and 2023).
During epidemiological week 41 (ending 15 October
2023), two new cases of cVDPV1 were reported from
two newly affected health zones: Kiambi in Tanganyika
province and Mufunga-Sampwe in Haut Katanga
province. Furthermore, 33 environmental samples
collected in the provincial sites of Kinshasa, Equateur,
Haut Katanga, and Lualaba tested positive for cVDPV2,
of which 85.0% (n=25) were from Kinshasa province.
From epidemiological week 1 to week 41, a total of
186 confirmed circulating vaccine-derived poliovirus
(cVDPV) including 79 (42.5 %) cVDPV1 and 107
(57.5%) cVDPV2 have been reported. Haut Katanga and
Tanganyika provinces were the most affected, with 44
cases (33 cVDPV1 and 11 cVDPV2) and 41 cases (36
cVDPV1 and 5 cVDPV2) respectively.
From 1 January to 19 October 2023, a cumulative total of
3 630 AFP cases have been reported in 98.0% (n=509)
of the 519 health districts, with an estimated no polio AFP
rate of 7.2 per 100 000 population of less than 15 years
old (country target: ≥ 3/100 000). Nearly 60.0% (n=2 083)
of the AFP cases were notified by healthcare providers
(n= 2 083), followed by community health workers
(36.0%, n=1 310), relatives (3.1%, n=113), traditional
healers (0.5%, n=21) and non-government organizations
(0.4%, n=16).
The percentage of AFP cases notified within 7 days of
the onset of paralysis was 67.1% (target: ≥ 80 %), and
only 9.1% (target: ≥ 80%) of the collected samples
reached the laboratory for investigation within 3 days
or less; the remaining samples arrived late.
Since 2017 and as of 20 October 2023, there have
been a cumulative total of 23 648 AFP cases, with 938
(4.0%) confirmed polio cases including 722 (77.0%)
cVDPV2 and 216 (23.0%) cVDPV1. The highest
number of cases was reported in 2022 with a total
of 520 (55.4%) confirmed cVDPV cases, including
377 cVDPV2 and 143 cVDPV1. Haut Lomami and
Tanganyika provinces reported most cases with 185
cases (103 cVDPV1 and 82 cVDPV2) and 163 cases
(103 cVDPV1 and 82 cVDPV2) respectively.
From 20 October 2022 to 19 October 2023, of the
3 644 reported AFP cases, 46% (n=1 676) of those
aged between 6- 59 months, received more than four
Polio vaccine doses, while 16.0% (n=583) had an
unknown vaccination status, and 10.0% (n=365) had
zero Polio vaccine dose.
PUBLIC HEALTH ACTIONS
The Ministry of health is coordinating the
preparation and implementation of polio
vaccination campaigns in the affected provinces
and health zones with support from WHO and
other implementing partners.
WHO continues to support the training of national,
provincial and health zones surveillance officers
on electronic surveillance
Active Polio case search, case investigation and
supportive integrated supervisions in the affected
health zones are ongoing.
Annual review of environmental surveillance sites
is ongoing, and investigations of polioviruses
isolated from environmental samples are
underway.
SITUATION INTERPRETATION
Vaccine derived Polio disease remains a public health
concern in DRC. While efforts have been made to fulfill
two key indicators, namely AFP case investigation
within 48 hours, and stool sample collection adequacy,
there still a need to strengthen cases notification within
7 days of the onset of paralysis and ensure that samples are
shipped to the laboratory within 3 days or less. It’s worth noting
a significant community involvement in reporting AFP
cases, with nearly 36% of AFP cases reported.
The Government along with its partners should
enhance and maintain quality routine polio vaccination
activities, as well as targeted response
efforts in hard-to-reach areas to achieve the
national and global polio eradication objectives.
https://www.afro.who.int/countries/m...-october-2023\[]
Comment